Literature DB >> 16859661

Pro- and antiarrhythmic properties of a diet rich in fish oil.

Hester M Den Ruijter1, Géza Berecki, Tobias Opthof, Arie O Verkerk, Peter L Zock, Ruben Coronel.   

Abstract

Increased consumption of fish rich in omega-3 polyunsaturated fatty acids (omega3-PUFAs) is associated with decreased incidence of sudden cardiac death in post-myocardial infarction patients, but is also related to increased incidence of sudden death and arrhythmias in patients with acute myocardial ischemia. This review discusses the possible pro- and antiarrhythmic mechanisms of omega3-PUFAs in relation to various cardiac pathologies. Differences between circulating and incorporated omega3-PUFAs with respect to electrophysiology are emphasized. We conclude that omega3-PUFAs alter cardiac electrophysiology and thereby may be pro- or antiarrhythmic, dependent on the mechanism of arrhythmia. As omega3-PUFAs may be antiarrhythmic under conditions that favour triggered activity, they may facilitate re-entrant arrhythmias. This may explain the contradictory outcomes of increased intake of fish oil on sudden death and arrhythmias in clinical trials. Advice to increase intake of omega3-PUFA supplements or fatty fish should be tailored to individual patients with respect to the arrhythmogenic mechanisms associated with the underlying pathology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16859661     DOI: 10.1016/j.cardiores.2006.06.014

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  29 in total

1.  Omega-3 polyunsaturated fatty acids (PUFAs or fish oils) and atrial fibrillation.

Authors:  T Opthof; H M Den Ruijter
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

Review 2.  Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease.

Authors:  Baukje de Roos; Yiannis Mavrommatis; Ingeborg A Brouwer
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

3.  Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications.

Authors:  Arja T Erkkilä; Ursula S Schwab; Vanessa D F de Mello; Tiina Lappalainen; Hanna Mussalo; Seppo Lehto; Virpi Kemi; Christel Lamberg-Allardt; Matti I J Uusitupa
Journal:  Eur J Nutr       Date:  2008-07-29       Impact factor: 5.614

Review 4.  n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: Principles, Practices, Pitfalls, and Promises - A Contemporary Review.

Authors:  Richard Kones; Scott Howell; Umme Rumana
Journal:  Med Princ Pract       Date:  2017-11-29       Impact factor: 1.927

Review 5.  Do Omega-3 Fatty Acids Decrease the Incidence of Atrial Fibrillation?

Authors:  Peter Ofman; Adelqui Peralta; Peter Hoffmeister; J Michael Gaziano; Luc Djousse
Journal:  J Atr Fibrillation       Date:  2013-06-30

Review 6.  Should Physicians Continue to Recommend Fish Oil for Patients with Atrial Fibrillation?

Authors:  Victoria M Robinson; Peter R Kowey
Journal:  J Atr Fibrillation       Date:  2012-10-06

7.  Omega-3 fatty acids, ventricular arrhythmias, and sudden cardiac death: antiarrhythmic, proarrhythmic, or neither.

Authors:  Christine M Albert
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-06-01

8.  Dietary omega-3 fatty acids and susceptibility to ventricular fibrillation: lack of protection and a proarrhythmic effect.

Authors:  George E Billman; Cynthia A Carnes; Philip B Adamson; Emilio Vanoli; Peter J Schwartz
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-02-14

9.  Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.

Authors:  Robert M Carney; Kenneth E Freedland; Eugene H Rubin; Michael W Rich; Brian C Steinmeyer; William S Harris
Journal:  JAMA       Date:  2009-10-21       Impact factor: 56.272

10.  The response to fish oil in patients with heart disease depends on the predominant arrhythmia mechanism.

Authors:  Hester M Den Ruijter; Ruben Coronel
Journal:  Cardiovasc Drugs Ther       Date:  2009-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.